• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global companion diagnostics market grew at a CAGR of around 15% during 2014-2019. Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients.

The growing prevalence of cancer, in confluence with the escalating demand for in-vitro diagnostics and targeted therapies, represents one of the key factors impelling the global companion diagnostics market growth. Apart from this, personalized healthcare (PHC) and precision medicine are also gaining traction in the treatment of cardiovascular, neurological, infectious and inflammatory diseases, which, in turn, is bolstering the growth of the market. Furthermore, the escalating demand for next-generation sequencing (NGS), the rising number of clinical trials and the increasing focus on the co-development of drugs and diagnostic technologies are contributing to the market growth. The introduction of new biomarkers, rising approvals of companion diagnostics and increasing collaboration between companies to develop novel companion diagnostic products are some of the other factors positively influencing the market growth. Currently, due to the spread of the coronavirus disease (COVID-19), diagnostic service providers are providing test services to healthcare providers. They are also utilizing companion diagnostics to detect the efficacy of COVID-19 drugs among patients undergoing oncology therapies. Looking forward, IMARC Group expects the global companion diagnostics market to continue its strong growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product & services, technology, indication and end-user.

Breakup by Product & Service:

  • Assays, Kits and Reagents
  • Software and Services
     

Breakup by Technology:

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Real-time PCR (RT-PCR)
  • Gene Sequencing
  • Others 
     

Breakup by Indication:

  • Cancer
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • Melanoma
    • Others
  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others
     

Breakup by End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global companion diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global companion diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product & services?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global companion diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Companion Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product & Service
    6.1    Assays, Kits and Reagents
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Software and Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Technology
    7.1    Immunohistochemistry (IHC)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Polymerase Chain Reaction (PCR)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    In-situ Hybridization (ISH)
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Real-time PCR (RT-PCR)
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Gene Sequencing
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Indication
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Major Types
           8.1.2.1 Lung Cancer
           8.1.2.2 Breast Cancer
           8.1.2.3 Colorectal Cancer
           8.1.2.4 Gastric Cancer
           8.1.2.5 Melanoma
           8.1.2.6 Others
        8.1.3 Market Forecast
    8.2    Neurological Diseases
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Infectious Diseases
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Cardiovascular Diseases
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by End User
    9.1    Pharmaceutical & Biopharmaceutical Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Reference Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Contract Research Organizations
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis 
        15.3.2    Agilent Technologies
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis 
        15.3.3    BioMerieux
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis 
        15.3.4    Danaher Corporation
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis 
        15.3.5    Roche Holding AG
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.4 SWOT Analysis
        15.3.6    Myriad Genetics Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Siemens Healthcare
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Thermo Fisher Scientific Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis


List of Figures

Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2019
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2019
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2019
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2019
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2019
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 90: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 91: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 92: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 93: Global: Companion Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2020-2025
Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2020-2025
Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2020-2025
Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Companion Diagnostics Market Structure
Table 8: Global: Companion Diagnostics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links